Jacobs Levy Equity Management
YTEN

Jacobs Levy Equity Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Jacobs Levy Equity Management’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1
Closed -$49K – 1037
2013
Q2 		$49K Buy
+1
New +$96.7K ﹤0.01% 954

Other funds holding YTEN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

Jacobs Levy Equity Management's YTEN Position: Q3 2013 in Review

Jacobs Levy Equity Management sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q3 2013, closing a stake of 1 share — an estimated $49K sold.

Jacobs Levy Equity Management first reported a position in YTEN in Q2 2013 and held it in 1 quarter. The position peaked at $49K in Q2 2013. 16 funds tracked by Wall St. Rank hold YTEN as of Q3 2013.

  • Jacobs Levy Equity Management reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 1 Yield10 Bioscience, Inc. Common Stock share in Q3 2013, an estimated $49K.
  • Jacobs Levy Equity Management first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
  • Jacobs Levy Equity Management's Yield10 Bioscience, Inc. Common Stock position peaked at $49K in Q2 2013.
  • 16 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q3 2013.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2013, filed 14 Nov 2013.